Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | PPM1B | O75688 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3717973 | 0.92 | CA12 (0.47) | LOXL2CYP4F2CYP4A11 | |
| SCHEMBL9378795 | 0.88 | CYP4F2 (0.50) | LOXL2CYP4F2CYP4A11TSHRRAB9A | |
| SCHEMBL9375934 | 0.88 | CYP4F2 (0.50) | LOXL2CYP4F2CYP4A11TSHRRAB9A | |
| SCHEMBL10374052 | 0.88 | CYP4F2 (0.50) | LOXL2CYP4F2CYP4A11TSHRRAB9A | |
| SCHEMBL18691151 | 0.87 | TP53 (0.48) | CYP4F2CYP4A11TSHRRAB9APOLB | |
| SCHEMBL15981992 | 0.86 | LOXL2 (0.41) | LOXL2CYP4F2CYP4A11TSHRRAB9A | |
| SCHEMBL8416867 | 0.84 | GRM2 (0.52) | LOXL2CYP4F2CYP4A11 | |
| SCHEMBL9133887 | 0.83 | TSHR (0.47) | LOXL2TSHRRAB9AALDH1A1NPC1 | |
| SCHEMBL15667202 | 0.83 | KMO (0.47) | SMN1; SMN2MRGPRX4HPGD | |
| SCHEMBL8415860 | 0.81 | LOXL2 (0.47) | LOXL2CYP4F2CYP4A11TSHRRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710159-A1 | CATALYST COMPONENTS FOR PROPYLENE POLYMERIZATION | W. R. Grace & Co. - Conn. (US) | 2020-09-23 | — | — | EP | claimed |
| US-8344079-B2 | Molar ratio modifications to larger polyolefin catalysts | BASF CORPORATION (US) | 2013-01-01 | — | — | US | claimed |
| JP-2011508053-A | — | — | 2011-03-10 | — | — | JP | claimed |
| EP-2242776-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF Corporation (US) | 2010-10-27 | — | — | EP | claimed |
| WO-2009088596-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF CATALYSTS LLC (US) | 2009-07-16 | — | — | WO | claimed |
| US-20090171044-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF CATALYSTS LLC (US) | 2009-07-02 | — | — | US | claimed |
| US-20260103548-A1 | PROCESS FOR PRODUCING POLYPROPYLENE-ETHYLENE RANDOM COPOLYMER RESIN WITH SUSTAINABLE REACTOR OPERABILITY | W. R. GRACE & CO.-CONN. | 2026-04-16 | — | — | US | disclosed |
| US-20250235842-A1 | GAS-PHASE PROCESS FOR MAKING POLYPROPYLENE RANDOM COPOLYMERS | W.R. GRACE & CO.-CONN (US) | 2025-07-24 | — | — | US | disclosed |
| US-20250145745-A1 | HIGH MFR POLYPROPYLENE FOR MELTBLOWN NONWOVEN APPLICATIONS | W. R. GRACE & CO.-CONN. | 2025-05-08 | — | — | US | disclosed |
| US-12240925-B2 | Process for preparing solid catalyst components for olefin polymerization | W. R. GRACE & CO.- CONN. (US) | 2025-03-04 | — | — | US | disclosed |
| US-20240343840-A1 | PROCESS FOR PRODUCING POLYOLEFIN GRANULAR RESIN WITH INCREASED SETTLED BULK DENSITY | W.R. GRACE & CO.-CONN. (US) | 2024-10-17 | — | — | US | disclosed |
| CN-118339199-A | Gas phase process for preparing polypropylene random copolymer | 格雷斯公司 | 2024-07-12 | — | — | CN | disclosed |
| EP-4396243-A1 | CATALYST COMPONENT FOR PROPYLENE POLYMERIZATION WITH IMPROVED CATALYST PERFORMANCE | W.R. GRACE & CO.-CONN. (US) | 2024-07-10 | — | — | EP | disclosed |
| EP-0972776-B1 | A phosphine sulfide, a manufacturing process therefor and a use thereof | MITSUI CHEMICALS INC (JP) | 2003-04-23 | — | — | EP | disclosed |
| EP-0950649-B1 | A process for preparing oxyalkylene derivatives in the presence of phosphine oxides | MITSUI CHEMICALS INC (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-6153794-A | Phosphine sulfide, a manufacturing process therefor and use thereof | MITSUI CHEMICALS, INC. (JP) | 2000-11-28 | — | — | US | disclosed |
| US-6130346-A | ESTERIFICATION, CARBONATION, SULFONATION, ETHERIFICATION | MITSUI CHEMICALS, INC. (JP) | 2000-10-10 | — | — | US | disclosed |
| EP-0972776-A1 | A phosphine sulfide, a manufacturing process therefor and a use thereof | Mitsui Chemicals, Inc. (JP) | 2000-01-19 | — | — | EP | disclosed |
| CN-1235141-A | Process for preparing organic compound | MITSUI CHEMICALS INC (JP) | 1999-11-17 | — | — | CN | disclosed |
| EP-0950649-A1 | A process for preparing oxyalkylene derivatives in the presence of phosphine oxides | Mitsui Chemicals, Inc. (JP) | 1999-10-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12240925-B2 | Process for preparing solid catalyst components for olefin polymerization | POF1B, PPOX, OGFOD1 | LOXL2 4193/4885CYP4F2 26/4885CYP4A11 52/4885 |
| US-20260103548-A1 | PROCESS FOR PRODUCING POLYPROPYLENE-ETHYLENE RANDOM COPOLYMER RESIN WITH SUSTAINABLE REACTOR OPERABILITY | CCT4, PTGER1, TCP1 | LOXL2 3032/4885CYP4F2 597/4885CYP4A11 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.